{"id":977436,"date":"2026-06-30T17:33:14","date_gmt":"2026-06-30T21:33:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"modified":"2026-06-30T17:33:14","modified_gmt":"2026-06-30T21:33:14","slug":"wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","title":{"rendered":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, June  30, 2026  (GLOBE NEWSWIRE) &#8212; The law firm of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l-RtQbW-wjk_rk-WApxVcnGgTeLDEbQuqUmB-UWeyDtKWmwGFwHqElh61EFN0XbHwF7Y3zpueBVbnQO7HkTxdDFFBUAP1E39AWf8KIzaO_4I2kXjGV7_7jihMtgWX76g0Xf-Kv6geVnt1AFUVPfVyTrac72-ZbBz0hY7vEpfyfluxk7rKSTPdtBC3BbI6v6Y\" rel=\"nofollow\" target=\"_blank\"><strong>Robbins Geller Rudman &amp; Dowd LLP<\/strong><\/a> announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the \u201cClass Period\u201d), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the <em>GeneDx <\/em>class action lawsuit. Captioned <em>Basma v. GeneDx Holdings Corp.<\/em>, No. 26-cv-00880 (D. Conn.), the <em>GeneDx <\/em>class action lawsuit charges GeneDx and certain of GeneDx\u2019s top executive officers with violations of the Securities Exchange Act of 1934.<\/p>\n<p align=\"left\">\n        <strong>If you suffered substantial losses and wish to serve as lead plaintiff of the <\/strong><br \/>\n        <strong><br \/>\n          <em>GeneDx <\/em><br \/>\n        <\/strong><br \/>\n        <strong>class action lawsuit, please provide your information here:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Dzbmj4FEhzi9CC5eiZJFsWV1F0NatC0l3EqdEjklHWZObKEmTVlSRSlaW0Vdn_7TeYAsbn1V52x4KiMNCMZVkhjZ1ETm_0_X3IG2ty7ehLS-CYqPIGH0p0PEmUG-uZwEnkXaq4LiA5GAIGBmX6BoQfVHljdgyZb2j6Gzbb8BF836f7IN7unZ4ZEHATaRILYykWnnWshQerRTJLoDKlE3EWncT1p6VNZ4Wzv0zuYbm80KOM0mM0aCF-IBbDkgrYI\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">\n        <strong>You can also contact attorneys <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZxymK6A3gNxxkAe62Qy7A-oUBARCoybHq4zaFSH-UxxLX1XoQHyqQ8OfyuK-VQ5caT0cYIk33KNxRvuxmhKPowfedP6Q96noh0oc_kMsVmZLjKSEOZMl7sEtZlwnMbAm14ilG7QLR5BB5iAPTFmtLB0tAK_06X6MwXNwEpnAPkI=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Ken Dolitsky<\/strong><br \/>\n        <\/a><br \/>\n        <strong> or <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eabqzNyk8WSpMCJ4l_WN8viKjksI28JNWAN3-MlyiBSc3eTgu_9WQuk9VXxNtwLt6zABnAnqAh1k1XvpC9Iam3g9yTnOZthS2ba_K_AWkOJX7q9pyaAcHHG-ZzHwnP-T2Jx9LA22xrUxik7e2LJd6A4wJxjvHi0qW88TR-tS1OU=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Michael Albert<\/strong><br \/>\n        <\/a><br \/>\n        <strong>of Robbins Geller by calling 800\/851-7783 or via e-mail at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CpFxQ_j9cgpSlrgrXPcUtz89V-sz8K0TkcQszMZfwAyJBs2o1a6e2-GDcWGLxSjUVodiyp0ds_6nJN0AwgZHiiZL-4vX4S5TbC_qIZ7THYM=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>info@rgrdlaw.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>.<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>CASE ALLEGATIONS:<\/strong> GeneDx is a genomics company that provides genetic testing services. On April 16, 2025, GeneDx announced an agreement to acquire Fabric Genomics. Fabric Genomics is a firm focused on AI-driven genomic interpretation.<\/p>\n<p align=\"justify\">The <em>GeneDx <\/em>class action lawsuit alleges that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose significant problems in Fabric Genomic\u2019s viability that would negatively impact GeneDx\u2019s overall business and operations.<\/p>\n<p align=\"justify\">On May 4, 2026, GeneDx announced its 2026 first quarter results, allegedly revealing a drop in adjusted gross margin from 74% to 69%, reduced projected earnings from $540-$555 million to $475-$490 million, and a $31.3 million impairment loss directly attributable to Fabric Genomics. On this news, the price of GeneDx stock dropped over 49%, according to the complaint.<\/p>\n<p align=\"left\">\n        <strong>THE LEAD PLAINTIFF PROCESS:<\/strong> The Private Securities Litigation Reform Act of 1995 permits any investor who purchased GeneDx common stock during the Class Period to seek appointment as lead plaintiff in the <em>GeneDx <\/em>class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the <em>GeneDx <\/em>class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the <em>GeneDx <\/em>class action lawsuit. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the <em>GeneDx <\/em>class action lawsuit.<\/p>\n<p align=\"left\">\n        <strong>ABOUT ROBBINS GELLER: <\/strong>Robbins Geller Rudman &amp; Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors \u2013 $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in <em>In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Dzbmj4FEhzi9CC5eiZJFsWV1F0NatC0l3EqdEjklHVy4YDR2WKKnkTJ2LyBCIfXvy8g64cfLAJFhHfJGDtylb14yrv2qqfuIITycOpwqy_rd9KwKQglf-4MCDJ98FZYUyIkI0fvwOyczajULC4a9km2_4cCZS_8O20fa3xz9ruLajavw3JRY_adOlPdCtp7wD6Kn83K9e0rsVqDx26NVQ==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud.html<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">Past results do not guarantee future outcomes.\u00a0<br \/>Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n<p align=\"left\">Contact:<br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Robbins Geller Rudman &amp; Dowd LLP <br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Ken Dolitsky<br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Michael Albert<br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 655 W. Broadway, Suite 1900, San Diego, CA 92101 <br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 800\/851-7783 <br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CpFxQ_j9cgpSlrgrXPcUt157W1RTWfpFsjV4XGOzKNJfNGK9A7UNtKUO7vqk46PChGx0kNXbcikCTatmn_8wW75C6toJqwwPd5IGwiP9yqM=\" rel=\"nofollow\" target=\"_blank\"><strong>info@rgrdlaw.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2NiMzM2YmUtMGE4ZS00ZjZhLTk0NzUtZWU1Mzk2OTZiMDFiLTExNDgxNTAtMjAyNi0wNi0zMC1lbg==\/tiny\/Robbins-Geller-Rudman-Dowd-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the \u201cClass Period\u201d), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx and certain of GeneDx\u2019s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-977436","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the \u201cClass Period\u201d), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx and certain of GeneDx\u2019s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact &hellip; Continue reading &quot;WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T21:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law\",\"datePublished\":\"2026-06-30T21:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"},\"wordCount\":580,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\",\"name\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\",\"datePublished\":\"2026-06-30T21:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","og_locale":"en_US","og_type":"article","og_title":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk","og_description":"SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the \u201cClass Period\u201d), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.), the GeneDx class action lawsuit charges GeneDx and certain of GeneDx\u2019s top executive officers with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the GeneDx class action lawsuit, please provide your information here: https:\/\/www.rgrdlaw.com\/cases-genedx-holdings-corp-class-action-lawsuit-wgs.html You can also contact &hellip; Continue reading \"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-30T21:33:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law","datePublished":"2026-06-30T21:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"},"wordCount":580,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/","name":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=","datePublished":"2026-06-30T21:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1MzAxOCM3Njc5NTYxIzIxMzY1Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wgs-investor-deadline-genedx-holdings-corp-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-rgrd-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"WGS INVESTOR DEADLINE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &#8211; RGRD Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/977436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=977436"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/977436\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=977436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=977436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=977436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}